Government pledges to improve medicine safety in aged care

The Federal Government has committed to improving medicine safety in aged care, as part of a $537 million response to the interim report of...

Barriers removed for pharmacists to seek mental health treatment

Changes in Australian mandatory reporting laws will remove barriers to mental health treatment for health professionals. Australian federal, state and territory health ministers at April’s...

How AI might help identify adverse drug events

The development of natural language processing (NLP) capabilities is opening new avenues for pharmacovigilance and pharmacists can play a key role in the process. US...

Pharmacist Insight – Older and Wiser

Dr Renly Lim is a Research Fellow at the University of South Australia working to expand the role of pharmacists in residential care facilities,...

PBS listings for cancer, Parkinson’s and motor neurone disease

Since 1 April, medicines crucial to those suffering from cancer, Parkinson’s and motor neurone disease have become available on the Pharmaceutical Benefits Scheme (PBS). The...

Amitriptyline for irritable bowel syndrome

Ordinarily used to treat other conditions, this trycylic antidepressant performed well in a recent trial on people with IBS. Irritable bowel syndrome (IBS) is estimated...